Sotalol and beta blocker combination

It classifies as a class III agent in the Vaughan-Williams classification system for antiarrhythmic medications due to its predominant potassium channel blocking effect. Sotalol and dofetilide are potassium channel blocking drugs that display reverse use dependence such that repolarization is prolonged at slow heart rates

2024-03-29
    Pro chamber for inhaler
  1. 61; 95% CI, 0
  2. Tiredness, slow heartbeat, and dizziness may occur
  3. Sotalol belongs to the group of medicines known
  4. Additive hypotensive effects may occur
  5. g
  6. 30 to 0
  7. doi: 10
  8. C alone (0